Background/Objectives: Cervical cancer is currently the fourth leading cause of cancer in women. It is primarily caused by Human Papilloma Virus (HPV) infections. Primary prevention methods, such as vaccines, and secondary prevention strategies, such as screening, have significantly reduced the burden of these diseases. The screening could be a crucial factor in the early diagnosis. This study aims to estimate the access of migrant and refugee populations to cervical cancer screening (CCS). Methods: A meta-analysis of scientific literature present in Pubmed and Scopus databases was conducted according to the PRISMA 2020 guidelines. Eighty-seven cross-sectional and five cohort unique studies were examined, to evaluate the participation of migrant and refugee populations to CCS programs in different world regions. Results: Statistical analysis was performed using STATA 14.2 software. Among cross-sectional studies, mean regular adherence to CCS for migrant and refugees resulted being 56% (95% CI 53–60), while participation at least once is 60% (95% CI 54–65). In cohort studies, regular adherence and participation at least once are, respectively, 55% (95% CI 50–59) and 56% (95% CI 52–61). Conclusions: The results of this review show how migrant and refugee populations have limited access to prevention interventions due to several socio-cultural factors. Our work calls for public health professionals’ efforts in order to promote more inclusive policies and prevention strategies towards those populations, aiming to reduce disparities and public health expenditures.
背景/目的：宫颈癌目前是女性第四大常见癌症，主要由人乳头瘤病毒（HPV）感染引起。以疫苗为代表的一级预防措施和以筛查为主的二级预防策略已显著降低了此类疾病的负担，其中筛查是实现早期诊断的关键环节。本研究旨在评估移民与难民群体接受宫颈癌筛查的现状。方法：依据PRISMA 2020指南，对PubMed和Scopus数据库中的科学文献进行荟萃分析。共纳入87项横断面研究与5项队列研究，评估全球不同地区移民与难民群体参与宫颈癌筛查项目的情况。结果：使用STATA 14.2软件进行统计分析。横断面研究显示，移民与难民群体定期参与宫颈癌筛查的平均比例为56%（95% CI 53-60），至少参与一次的比例为60%（95% CI 54-65）。队列研究中，定期参与率与至少参与一次的比例分别为55%（95% CI 50-59）和56%（95% CI 52-61）。结论：本综述结果表明，受多重社会文化因素影响，移民与难民群体获得预防干预措施的机会有限。本研究呼吁公共卫生专业人员致力于推动更具包容性的政策与预防策略，以消除健康差异并降低公共卫生支出。
肿瘤(癌症)患者之家